2 Top Biotech Stocks to Buy in August
Last year was no small challenge for many investors, but the tides appear to have shifted for the better so far in 2023. Some companies have even performed well throughout all these ups and downs.
Consider biotech giants Vertex Pharmaceuticals (NASDAQ: VRTX) and Eli Lilly (NYSE: LLY). It is no wonder these corporations have been performing so well; both have excellent long-term prospects that make their shares worth buying this month (or almost any month) and holding onto for a long time.
Let's see why investors might consider both stocks for their portfolios now.
Source Fool.com
Vertex Pharmaceuticals Inc. Aktie
470,00 €
0,44 %
Vertex Pharmaceuticals Inc. ist ein klarer Community-Favorit mit mehr Buy- als Sell-Einschätzungen.
Trotz eines Kursziels von 450 €, das unter 470.0 € liegt, ergibt sich für Vertex Pharmaceuticals Inc. ein negatives Potenzial von -4.26%.
